ReviewVirology journal2025
Analysis of epidemiological characteristics of influenza viruses in Fengdu district, Chongqing, China, from 2022 to 2024.
Review in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Research on influenza surveillance and a prediction model based on multi-source data.BMC medical informatics and decision making · 2026Article
- Pathogen profiles and co-detection characteristics of acute respiratory infections based on active surveillance in a large district of southern China.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the epidemiological characteristics of influenza viruses in Fengdu, Chongqing, and provide a scientific basis for influenza prevention and control in the region.
methodsPharyngeal swab samples were collected from influenza-like illness cases at Fengdu Traditional Chinese Medicine Hospital from 2022 to 2024 for etiological testing. Virus positivity rates across different years, genders, and occupations were compared, along with inflammatory indicators such as blood routine parameters between influenza A and B virus infections.
resultsA total of 19,576 nasopharyngeal swab samples were tested from 2022 to 2024, with 5073 positive for influenza viruses (detection rate: 25.91%). There were significant differences in positivity rates across different years (P < 0.001). The peak positivity rate for influenza A virus occurred in 2022 (27.15%), while influenza B virus had its highest detection rate in 2024 (5.67%). The epidemic peak for influenza A was from December to April of the following year, dominated by the H3N2 subtype; for influenza B, the peak was from December to March, with the Victoria lineage as the predominant strain. In terms of age distribution, the highest positivity rate for influenza A was observed in school-aged children aged 6 ~ 13 years (23.12%), while influenza B predominantly affected individuals aged 45 ~ 59 years (3.61%). Among different occupations, students had significantly higher positivity rates for both influenza A and B compared to other occupations (P < 0.05). The influenza A group had higher white blood cell count (WBC), neutrophil count (NC), neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP), and serum amyloid A (SAA) levels than the influenza B group (P < 0.05).
conclusionIn Fengdu County, Chongqing, influenza epidemics exhibit distinct winter-spring seasonal patterns. Surveillance data indicate that influenza A (H3N2) constitutes the predominant subtype among type A viruses, while Victoria lineage dominates influenza B circulation. Epidemiological analysis reveals school-aged children demonstrate particular susceptibility to influenza A infections, whereas middle-aged adults show heightened vulnerability to influenza B. Public health recommendations emphasize: targeted vaccination campaigns for high-risk populations, enhanced health education initiatives, and utilization of inflammatory biomarkers to facilitate early differential diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.